Press release
Nadrich & Cohen, LLP Now Investigating Pradaxa Side Effects Claims in All 50 States
National law firm Nadrich & Cohen, LLP is now offering free initial case evaluations to patients in all 50 states who suffered side effects caused by Pradaxa.Los Angeles, CA, January 20, 2012 – Prominent national law firm Nadrich & Cohen, LLP is pleased to announce that the firm is now representing individuals who believe they were injured by Pradaxa, a blood thinner used to treat patients with a heart rhythm problem known as atrial fibrillation. A recent research study has linked Pradaxa (dabigatran) to an increased risk of heart attack, angina and other serious complications in certain patients.
Pradaxa is manufactured by German pharmaceutical company Boehringer Ingelheim GmbH (BING) and was first approved for use as an anticoagulant by the FDA in 2010. In addition to treating patients with atrial fibrillation, the drug is also used to prevent blood clots in patients who’ve undergone joint replacement surgery.
On January 9, a paper published in the Archives of Internal Medicine suggested that patients who take Pradaxa are as much as 33% percent more likely to experience a heart attack or angina compared with patients who used another type of blood thinning agent. Researchers pooled data from seven different research studies involving 30,514 patients who were given dabigatran, warfarin, enoxaparin or a placebo.
In addition to the potential risk of heart attack associated with Pradaxa, the drug has also been linked to other serious side effects, including gastrointestinal bleeding, cerebral and brain hemorrhaging, ulcers, bleeding in the kidneys and in some cases, death. According to a November 2011 Reuters article, Boehringer acknowledged that the drug had caused approximately 260 deaths worldwide.
If you or a loved one experienced a heart attack, internal bleeding or other complications after taking Pradaxa, you can complete a MedWatch form by visiting the Food and Drug Administration’s website. It is also recommended that you contact an experienced Pradaxa injury attorney to discuss your legal rights.
Nadrich & Cohen LLP offers confidential, no-cost consultations to Pradaxa users who believe they were harmed by the drug. Help is available by calling 1-800-722-0765 or by completing an online case evaluation form at www.personalinjurylawcal.com.
Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.
In addition to handling Pradaxa side effects claims, Nadrich & Cohen, LLP investigates cases involving Accutane, Avandia, DePuy Hip Implants, Zimmer Hips, Wright Conserve Hips, Vaginal Mesh, Stevens-Johnson Syndrome, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan.
The time you have to file an injury claim is limited, so it’s important to act as quickly as possible to protect your rights. Call 1-800-722-0765 today to speak with a qualified personal injury expert or visit www.personalinjurylawcal.com.
Nadrich & Cohen LLP is a national law firm specializing in representing individuals who have been injured by defective medical devices, harmful prescription drugs, faulty products, car accidents, motorcycle accidents and dog bites.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Nadrich & Cohen, LLP Now Investigating Pradaxa Side Effects Claims in All 50 States here
News-ID: 207996 • Views: …
More Releases from Nadrich & Cohen LLP
Yaz Lawsuit Settlements Reach $142 Million
Nadrich & Cohen, LLP reports that Bayer is continuing to offer settlements to plaintiffs involved in federal Yaz side effects litigation.
Los Angeles, CA, April 27, 2012 – Nadrich & Cohen, LLP reports that German drug-maker Bayer AG has settled approximately 651 Yaz side effects lawsuits totaling $142 million. Earlier this month, it was reported that the drug-maker had reached settlements in approximately 500 cases filed by women who claimed…
Yaz, Yasmin to Get New Labels as FDA Warns of Blood Clot Risk
Nadrich & Cohen, LLP reports that Yaz and similar birth control pills are to receive updated warning labels advising patients of the risk for developing serious blood clots.
Los Angeles, CA, April 10, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has ordered Bayer to produce new warning labels for several of its oral contraceptives, including Yaz, Yasmin and Beyaz.…
FDA Schedules Advisory Panel Meeting to Discuss Metal Hip Safety
Nadrich & Cohen, LLP reports that the FDA has scheduled an advisory panel to discuss the safety of metal hip implants.
Los Angeles, CA, March 29, 2012 – National law firm Nadrich & Cohen, LLP has learned that the U.S. Food and Drug Administration has a scheduled an advisory panel meeting to discuss the safety of metal hip implants and all-metal hip resurfacing systems.
The two-day panel, which is expected…
Pradaxa Side Effects Lawsuits Filed in Federal Court
Nadrich & Cohen, LLP reports that three Pradaxa side effects lawsuits have been filed in federal courts across the country.
Los Angeles, CA, March 7, 2012 – National law firm Nadrich & Cohen, LLP has learned that three Pradaxa side effects lawsuits have been filed against Boehringer Ingelheim, the drug’s manufacturer. The cases were filed in federal district courts located in Tennessee, Kentucky and Louisiana and it’s believed they are the…
More Releases for Pradaxa
Pradaxa Global Industry Report - History, Present and Future 2018
GET SAMPLE REPORT @ https://www.research2reports.com/sample-report-other-reports/pradaxa-market/71821
The global market size of Pradaxa is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023.
There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment.
For geography segment, regional supply, application-wise and type-wise demand, major…
Global Pradaxa Market Top Key Players - Pfizer, Bayer Healthcare, GlaxoSmithKlin …
A new and latest research report proposed by QYResearchReports.us renders a market summary of the Pradaxa Market industry. This widespread analysis comprises of market potentials.
This report studies Pradaxa in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
Get Sample Copy of this Report: https://www.qyresearchreports.us/request-sample/global-pradaxa-market-professional-survey-report-2017
This report focuses on…
Pradaxa Market- Global Industry Analysis, Growth and Forecast 2017- 2022
In this report, the global Pradaxa market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Request For Sample Of Global Pradaxa Market Research Report @ http://bit.ly/2g7KkJO
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Pradaxa in…
United States Pradaxa Market Report 2017
In this report, the United States Pradaxa market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Pradaxa in these regions, from…
Pradaxa Market 2017 - Pfizer, Bayer Healthcare, GlaxoSmithKline, Aspen Holdings
Apex Research, recently published a detailed market research study focused on the "Pradaxa Market" across the global, regional and country level. The report provides 360° analysis of "Pradaxa Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Pradaxa industry, and estimates the future trend of Pradaxa market on the basis of this…
Pradaxa Market by Type, Applications, Substrate Type, and by Region - Global For …
The Global Pradaxa Market Research Report 2017 renders deep perception of the key regional market status of the Pradaxa Industry on a Global level that primarily aims the core regions which comprises of continents like Europe, North America, and Asia and the key countries such as United States, Germany, China and Japan.
Free Sample PDF Copy of Pradaxa Market research report @ https://www.qyresearchgroups.com/request-sample/488034
The report on “Global Pradaxa Market” is a professional…
